(Q44618440)

4 December 2017

title

Retrospective study of hepatic enzyme elevations in children treated with olanzapine, divalproex, and their combination (English)

1 reference

4 December 2017

Retrospective Study of Hepatic Enzyme Elevations in Children Treated With Olanzapine, Divalproex, and Their Combination (English)

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

21 March 2024

author name string

Joseph Gonzalez-Heydrich

1

1 reference

4 December 2017

Darcy Raches

2

1 reference

4 December 2017

Alan Leichtner

4

1 reference

4 December 2017

Enrico Mezzacappa

5

1 reference

4 December 2017

Timothy E. Wilens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14560173

21 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14560173

21 March 2024

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0890856709619869?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

https://api.elsevier.com/content/article/PII:S0890856709619869?httpAccept=text/plain

21 March 2024

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Journal of the American Academy of Child and Adolescent Psychiatry

21 March 2024

published in

1 reference

4 December 2017

volume

42

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

1227-1233

1 reference

Hepatic morphology and function. Alterations associated with acute pancreatitis

4 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Idiopathic steatohepatitis in childhood: a multicenter retrospective study

21 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

21 March 2024

Safety of olanzapine

4

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Abnormalities of Liver Function in Acute Pancreatitis

21 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Olanzapine (Zyprexa): suspected serious reactions

21 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Special issues in the treatment of paediatric bipolar disorder

21 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Pancreatitis associated with valproic acid: a review of the literature

21 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs.

21 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder

21 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Idiosyncratic reactions: new methods of identifying high-risk patients

21 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Olanzapine and pancreatitis

21 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Evidence for a trigger function of valproic acid in xenobiotic-induced hepatotoxicity.

21 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Childhood-onset schizophrenia: an open-label study of olanzapine in adolescents

21 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Steatohepatitis in obese children: a cause of chronic liver dysfunction

21 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Dosing the antipsychotic medication olanzapine

21 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Acute pancreatitis coincident with valproate use: a critical review

21 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.

21 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Drug metabolism and atypical antipsychotics

21 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Olanzapine-induced diabetic ketoacidosis

21 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Cytochrome P-450--catalyzed formation of delta 4-VPA, a toxic metabolite of valproic acid

21 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Persistent hyperaminotransferasemia resolving after weight reduction in obese children

21 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Effects of development on olanzapine-associated adverse events

21 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Routine laboratory monitoring for serious adverse effects of antiepileptic medications: the controversy

21 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

Fatal pancreatitis associated with valproic acid: review of the literature.

21 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00004583-200310000-00014

21 March 2024

Identifiers

1 reference

release_v34iub3aa5hpngn2weodwvp5oi

4 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v34iub3aa5hpngn2weodwvp5oi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference